(Q42985148)

English

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study

scientific article published on 4 February 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Japanese encephalitis virus

0 references

Japanese encephalitis

1 reference

based on heuristic

inferred from title

Japanese encephalitis vaccine

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Elisabeth Schuller

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Christoph S Klade

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Gabriele Wölfl

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Astrid Kaltenböck

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Shailesh Dewasthaly

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Erich Tauber

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

0 references

publication date

4 February 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2188-2193

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

The epidemiology of Japanese encephalitis: prospects for prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Japanese encephalitis vaccine for travelers: exploring the limits of risk.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Short-term safety of live attenuated Japanese encephalitis vaccine (SA14-14-2): results of a randomized trial with 26,239 subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: immunogenicity and anamnestic responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Fatal Japanese encephalitis in a Danish tourist visiting Bali for 12 days

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Japanese encephalitis after a 10-day holiday in Bali

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Tick-born encephalitis (TBE) vaccination in children: advantage of the rapid immunization schedule (i.e., days 0, 7, 21).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Tick-borne encephalitis (TBE) vaccination: applying the most suitable vaccination schedule.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Tick-borne encephalitis vaccines: past and present

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Kinetics of the immune response after primary and booster immunization against tick-borne encephalitis (TBE) in adults using the rapid immunization schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.12.062

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.12.062

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42985148&oldid=1975862950"